Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cost of Goods | N/A | N/A | N/A | N/A | 94 |
| Gross Profit | N/A | N/A | N/A | N/A | -94 |
| Operating Expenses | 26,459 | 19,376 | 11,656 | 6,173 | 3,561 |
| Operating Income | -26,459 | -19,376 | -11,656 | -6,173 | -3,655 |
| Interest Expense | N/A | 0 | 133 | 0 | 773 |
| Other Income | 1,758 | -203 | -188 | -2,165 | -7,733 |
| Pre-tax Income | -24,701 | -19,579 | -11,977 | -8,338 | -12,161 |
| Income Tax | 172 | 0 | 0 | 4 | N/A |
| Net Income Continuous | -24,873 | -19,579 | -11,977 | -8,342 | -12,161 |
| Net Income | $-24,873 | $-19,579 | $-11,977 | $-8,342 | $-12,161 |
| EPS Basic Total Ops | -1.70 | 2.09 | -1.63 | -2.83 | -6.02 |
| EPS Basic Continuous Ops | -1.70 | 2.09 | -1.63 | -2.83 | -6.02 |
| EPS Diluted Total Ops | -1.70 | 2.09 | -1.63 | -2.83 | -6.02 |
| EPS Diluted Continuous Ops | -1.70 | 2.09 | -1.63 | -2.83 | -6.02 |
| EBITDA(a) | $-26,454 | $-19,565 | $-11,839 | $-8,090 | $-11,258 |